|
|
|
| Effects of Callispheres Loadable Embolic Microspheres combined with Docetaxel TACE on bFGF VEGF and MVD in Patients with Primary Hepatocellular Carcinoma |
| DUAN Bin, LUO Chengjing, LUO Haiyang |
| The Seventh People's Hospital of Chengdu, Sichuan Chengdu 610021, China |
|
|
|
|
Abstract Objective: To investigate the influences of callispheres drug carrying embolic microspheres combined with docetaxel transcatheter arterial chemoembolization (TACE) on basic fibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and microvascular density (MVD) in patients with primary liver cancer. Methods: 84 cases of patients with primary liver cancer treated in our hospital from June 2013 to October 2017 were selected as the research subjects and were randomly divided into the observation group (n=42) and the control group (n=42). The control group was treated with Docetaxel Lipiodol Suspension TACE, and the observation group was treated with callispheres drug carrying embolic microspheres on the basis of the control group. The short-term curative effect, the change of liver function index, the occurrence of adverse reactions and the expressions of bFGF, VEGF and MVD were compared between the two groups. Results: The effective rate and disease control rate in the observation group were higher than those in the control group (P<0.05); The serum levels of aspartate aminotransferase (ASL), glutamate aminotransferase (ALT) and total bilirubin (TBIL) in the two groups were slightly higher than those before treatment, the level of albumin (ALB) was slightly lower than before treatment,but there was no significant difference between the two groups (P>0.05); The incidence of adverse reactions such as fever, abdominal pain, nausea, vomiting and so on in the observation group were slightly lower than those in the control group,but there was no significant difference between the two groups (P>0.05); 1 month after treatment, the VEGF and MVD values in the control group did not change significantly compared with those before treatment (P>0.05), the bFGF levels of the two groups were lower than those before the treatment (P<0.05), there were statistically significant differences in bFGF, VEGF and MVD between groups (P<0.05). Conclusion: Callispheres drug carrying embolic microspheres combined with docetaxel TACE in the treatment of patients with primary liver cancer can obtain good short-term curative effect, the security is relatively high, and can inhibit the expressions of bFGF, VEGF and MVD to a certain extent.
|
|
|
|
|
|
[1] 张惠洁,郭卫东,屈振杰.TACE联合索拉菲尼治疗原发性肝癌的疗效观察及血清VEGF、bFGF水平的变化[J].现代肿瘤医学,2015,23(21):3164~3168.
[2] 李静娴,姜艳萍,王家平,等.葡聚糖微球联合多西紫杉醇介入治疗原发性肝癌的临床疗效[J].实用放射学杂志,2017,33(5):739~741.
[3] 刘金,曹刚,张根山,等.国产CalliSpheres载药微球治疗原发性肝癌12例[J].介入放射学杂志,2017,26(11):993~998.
[4] Lencioni R,Llovet JM. Modified RECIST(mRECIST)assessment for hepatocellular carcinoma[J]. Semin Liver Dis ,2010,30(1):52~ 60.
[5] Tomimatsu M, Ishiguro N, Taniai M, et al. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma) in Japan[J]. Cancer,2015,72(3):683~688.
[6] 颜綦先,肖潇,崔红莉,等.生物微球联合碘油经肝动脉栓塞化疗治疗原发性肝癌临床观察[J].实用肝脏病杂志,2015,18(3):245~248.
[7] 曹国洪,王凯,李佳琪,等.CalliSpheres载药微球经动脉导管化疗栓塞治疗肝癌患者的有效性及安全性分析[J].中国介入影像与治疗学,2018,15(1):42~46.
[8] 张国强.艾迪注射液和抗癌消肿护肝汤联合TACE治疗中晚期原发性肝癌疗效观察[J].实用临床医药杂志,2015,19(1):75~77.
[9] 柳春霞,朱琳,李雅菁.超声微泡介导载多西紫杉醇脂质对肝癌大鼠MVD、CD34、VEGF水平的影响[J].现代医学,2018,46(1):80~82.
[10] 冯众一,高鹏,谭文翔,等.原发性肝癌TACE介入治疗前后血清VEGF和bFGF水平变化及临床意义[J].中国现代普通外科进展,2015,18(2):154~158.
[11] 王雨,唐腾骞,张辉,等.CT及多层螺旋CT对索拉菲尼治疗原发性肝癌前后的评判对比研究[J].肿瘤药学,2016,6(6):451~455.
[12] 黄长山,余伟,王谦,等.索拉菲尼与TACE联合治疗原发性肝癌的临床效果及对bFGF、VEGF水平的影响[J].实用癌症杂志,2017,32(6):943~945. |
|
|
|
2019, Vol. 25 
